Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 100

Similar articles for PubMed (Select 18054831)

1.

Expression profiles in malignant fibrous histiocytomas: clues for differentiating 'spindle cell' and 'pleomorphic' subtypes.

Scapolan M, Perin T, Wassermann B, Canzonieri V, Colombatti A, Italia F, Spessotto P.

Eur J Cancer. 2008 Jan;44(2):298-309. Epub 2007 Dec 4.

PMID:
18054831
2.

Gene expression analysis of soft tissue sarcomas: characterization and reclassification of malignant fibrous histiocytoma.

Nakayama R, Nemoto T, Takahashi H, Ohta T, Kawai A, Seki K, Yoshida T, Toyama Y, Ichikawa H, Hasegawa T.

Mod Pathol. 2007 Jul;20(7):749-59. Epub 2007 Apr 27.

3.

Malignant fibrous histiocytoma--pleomorphic sarcoma, NOS gene expression, histology, and clinical course. A pilot study.

Daigeler A, Klein-Hitpass L, Stricker I, Müller O, Kuhnen C, Chromik AM, Steinstraesser L, Goertz O, Steinau HU, Lehnhardt M.

Langenbecks Arch Surg. 2010 Mar;395(3):261-75. doi: 10.1007/s00423-009-0465-0. Epub 2009 Jan 22. Erratum in: Langenbecks Arch Surg. 2009 May;394(3):589. Adrien, Daigeler [corrected to Daigeler, Adrien]; Ludger, Klein-Hitpass [corrected to Klein-Hitpass, Ludger];Ingo, Stricker [corrected to Stricker, Ingo]; Oliver, Müller [corrected to Müller, Oliver]; Cornelius, Kuhnen [corrected to Kuhnen, Cornelius]; Michael, Chromik Ansgar [corrected to Chromik, Ansgar Michael]; Lars, Steinstraesser [corrected to Steinstraesser, Lars]; Ole, Goertz [corrected to Goertz, Ole]; Hans-Ulrich, Steinau [corrected to Steinau, Hans-Ulrich]; Marcus, Lehnhardt [corrected to Lehnhardt, Marcus].

PMID:
19159951
4.

Prognostic significance of ezrin expression in pleomorphic malignant fibrous histiocytoma.

Kim MS, Cho WH, Song WS, Lee SY, Jeon DG.

Anticancer Res. 2007 Mar-Apr;27(2):1171-8.

5.

Establishment of a nude mouse transplantable model of a human malignant fibrous histiocytoma of the mandible with high metastatic potential to the lung.

Maeda T, Hashitani S, Zushi Y, Segawa E, Tanaka N, Sakurai K, Urade M.

J Cancer Res Clin Oncol. 2008 Sep;134(9):1005-11. doi: 10.1007/s00432-008-0366-6. Epub 2008 Mar 4.

PMID:
18317806
6.

MFH revisited: outcome after surgical treatment of undifferentiated pleomorphic or not otherwise specified (NOS) sarcomas of the extremities -- an analysis of 140 patients.

Lehnhardt M, Daigeler A, Homann HH, Schwaiberger V, Goertz O, Kuhnen C, Steinau HU.

Langenbecks Arch Surg. 2009 Mar;394(2):313-20. doi: 10.1007/s00423-008-0368-5. Epub 2008 Jun 27.

PMID:
18584203
7.

Giant cell type of primary intracranial malignant fibrous histiocytoma: a case report.

Maruno M, Ghulam Muhammad AK, Taguchi J, Suzuki T, Wada K, Isaka T, Yoshimine T.

Brain Tumor Pathol. 2006 Apr;23(1):65-70.

PMID:
18095121
9.

Serous and mucinous ovarian tumors express different profiles of MMP-2, -7, -9, MT1-MMP, and TIMP-1 and -2.

Brun JL, Cortez A, Commo F, Uzan S, Rouzier R, Daraï E.

Int J Oncol. 2008 Dec;33(6):1239-46.

PMID:
19020757
10.

Primary hepatic malignant fibrous histiocytoma: clinicopathologic characteristics and prognostic value of ezrin expression.

Li YR, Akbari E, Tretiakova MS, Hart J, Akbari M, Urbanski SJ, Gao ZH.

Am J Surg Pathol. 2008 Aug;32(8):1144-58. doi: 10.1097/PAS.0b013e3181659791. Review.

PMID:
18545143
11.

Malignant fibrous histiocytoma of larynx with giant cell: case report and histological-clinical considerations.

Anghelina F, Ioniţă E, Chiuţu L, Mogoantă CA, Ciolofan S, Iosif C, Ceauşu M.

Rom J Morphol Embryol. 2009;50(3):481-5.

12.

Matrix metalloproteinase (MMP)-1, -9 and -13 as prognostic factors in salivary gland cancer.

Luukkaa H, Klemi P, Hirsimäki P, Vahlberg T, Kivisaari A, Kähäri VM, Grénman R.

Acta Otolaryngol. 2008 Apr;128(4):482-90. doi: 10.1080/00016480801922895.

PMID:
18368586
13.
14.

Malignant fibrous histiocytoma of the conjunctiva.

Arora R, Monga S, Mehta DK, Raina UK, Gogi A, Gupta SD.

Clin Experiment Ophthalmol. 2006 Apr;34(3):275-8.

PMID:
16671910
15.

Matrix metalloproteinases-1 and -2, and tissue inhibitor of metalloproteinase-2 production is abnormal in bone marrow stromal cells of multiple myeloma patients.

Zdzisińska B, Walter-Croneck A, Kandefer-Szerszeń M.

Leuk Res. 2008 Nov;32(11):1763-9. doi: 10.1016/j.leukres.2008.04.001. Epub 2008 May 9.

PMID:
18472160
16.

Matrix metalloproteinases 2 and 9, E-cadherin, and beta-catenin expression in endometriosis, low-grade endometrial carcinoma and non-neoplastic eutopic endometrium.

Shaco-Levy R, Sharabi S, Benharroch D, Piura B, Sion-Vardy N.

Eur J Obstet Gynecol Reprod Biol. 2008 Aug;139(2):226-32. doi: 10.1016/j.ejogrb.2008.01.004. Epub 2008 Mar 4.

PMID:
18295959
17.

Expression of matrix metalloproteinases MMP-2 and MMP-9 in gastric cancer and their relation to claudin-4 expression.

Lee LY, Wu CM, Wang CC, Yu JS, Liang Y, Huang KH, Lo CH, Hwang TL.

Histol Histopathol. 2008 May;23(5):515-21.

PMID:
18283635
18.

Matrix metalloproteinase-2 and matrix metalloproteinase-9 expression in canine and feline meningioma.

Mandara MT, Pavone S, Mandrioli L, Bettini G, Falzone C, Baroni M.

Vet Pathol. 2009 Sep;46(5):836-45. doi: 10.1354/vp.08-VP-0185-M-FL. Epub 2009 Mar 9.

19.

Increased expression of matrix metalloproteinase-2 (MMP-2) predicts tumour recurrence and unfavourable outcome in non-small cell lung cancer.

Leinonen T, Pirinen R, Böhm J, Johansson R, Kosma VM.

Histol Histopathol. 2008 Jun;23(6):693-700.

PMID:
18366007
20.
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk